[1] |
Chan RJ, Cooper T, Kratz CP, et al. Juvenile myelomonocytic leukemia: A report from the 2 nd International JMML symposium[J]. Leuk Res, 2009, 33(3):355-362.
|
[2] |
Loh ML. Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia[J]. Br J Hematol, 2011, 152(6):677-687.
|
[3] |
Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues[M]. Lyon, France:IARC, 2008, 75-87.
|
[4] |
Niemeyer CM, Arico M, Basso G, et al. Chronic myelomonocytic leukemia in childhood: A retrospective analysis of 110 cases[J]. Blood, 1997, 89(10):3534-3543.
|
[5] |
Loh ML. Childhood myelodsyplastic syndrome: Focus on the approach to diagnosis and treatment of juvenile myelomonocytic leukemia[J]. Hematology, 2010, 357-362.
|
[6] |
Karow A, Baumann I, Niemeyer CM. Morphologic differential diagnosis of juvenile myelomonocytic leukemia-pitfalls apart from viral infection[J]. J Pediatr Hematol Oncol, 2009, 31(5):380.
|
[7] |
Yoshimi A, Kojima S, Hirano N. Juvenile myelomonocytic leukemia epidemiology, etiopathogenesis, diagnosis, and management considerations[J]. Pediatr Drugs, 2010, 12 (1):11-21.
|
[8] |
Niemeyer CM, Kratz CP. Pediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: Molecular classification and treatment options[J]. Br J Hematol, 2008, 140(6):610-624.
|
[9] |
Koike K, Matsuda K. Recent advances in the pathogenesis and management of juvenile myelomonocytic leukemia[J]. Br J Hematol, 2008, 141(5):567-575.
|